Novo Nordisk A/S (NYSE:NVO)
$ 135.57 1.54 (1.15%) Market Cap: 603.92 Bil Enterprise Value: 606.48 Bil PE Ratio: 46.91 PB Ratio: 42.10 GF Score: 92/100

Novo Nordisk A/S to Discuss Updated 2020 Outlook Call Transcript

Oct 09, 2020 / 06:30AM GMT
Release Date Price: $36.04 (+1.17%)
Operator

Welcome to Novo Nordisk A/S conference call. (Operator Instructions)

Today, I'm pleased to present President and CEO, Lars Fruergaard Jørgensen. Please go ahead with your meeting.

Lars Fruergaard JÃ;rgensen;S;President
Novo Nordisk A;CEO & Member of Management Board

¸ - /- -

Thank you very much, and welcome to this conference call regarding our updated outlook for 2020. We have just finalized our third quarter results, and that has led to a revision of our outlook for the year. And according to the disclosure rules, we have to get that updated outlook announced to the market as soon as possible. That's why we have called for this meeting today.

With me, I have our CFO, Karsten Munk Knudsen, and we have scheduled up to 30 minutes for this call. We'll start by showing a few slides to explain the change and then we have a Q&A session. I'd like to remind you that we will have the full detailed Q3 announcement on 30th of October. Hence, we would like today to focus on the updated

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot